解决喘库存吸入器政策实施和由此产生的规划的可持续性关键障碍
Semmy A Adeleke1, Ana Ongtengco2, Caroline Youssef3
1College of Medicine, University of Illinois at Chicago, Chicago, Illinois.
概括
在伊利诺伊州学校实施股票吸入器计划面临着责任和资金等障碍. 战略参与和资源对于可持续的儿童喘管理至关重要.
科学领域:
- 儿科喘管理 儿科喘管理
- 公共卫生政策 公共卫生政策
- 学校卫生计划 学校卫生计划
背景情况:
- 喘是伊利诺伊州儿童的重大健康问题.
- 在17个州存在股票吸入器法律,但实施不一致.
- 社会决定因素对喘管理策略有很大的影响.
研究的目的:
- 为了确定在伊利诺伊州学校实施股票吸入器计划的障碍.
- 确定以学校为基础的喘护理可持续性的战略.
- 为应对儿科喘管理方面的挑战.
主要方法:
- 在伊利诺伊州对高喘负担的学区进行了半结构化采访.
- 利用专题分析来识别对计划可持续性的"威胁".
- 综合了数据,并向利益相关者提供了减缓策略的发现.
主要成果:
- 确定了25个阻碍库存吸入器计划实施和可持续性的障碍.
- 关键的障碍包括责任,后续护理,资金,药房实践和人员.
- 一个全州联盟和一个国家工具包被开发来支持可持续性.
结论:
- 有效的利益相关者参与对于成功的库存吸入器计划至关重要.
- 解决已识别的障碍对于项目启动和维护至关重要.
- 需要合作解决方案来改善基于学校的喘护理,并减少健康差异.
相关概念视频
Inhaled Medications
250
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
250
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Asthma-IV: Nursing Management
3.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.0K
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
236
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
236
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K


